Is There a Limit to PTCA in Elderly Patients?

  • Francesco Bovenzi
  • Roberto Lorenzoni
  • Mauro Lazzari
  • Andrea Boni
  • Cristina Gemignani
Conference paper


Life expectancy in the western world is steadily increasing; as result, ischemic cardiopathy has a higher incidence in the population. Moreover, highly effective therapies have become available for treating this disease, which has led to an increase in the number of chronically ill patients. It can therefore be presumed that within the next few years the number of patients in their 80s and 90s will be much greater than today.


Percutaneous Coronary Intervention Acute Coronary Syndrome Acute Myocardial Infarction Stable Angina Primary Angioplasty 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27(11):1341–1381PubMedCrossRefGoogle Scholar
  2. 2.
    MacDonald P, Johnstone D, Rockwood K (2000) Coronary artery bypass surgery for elderly patients: is our practice based on evidence or faith? Can Med Ass J 162(7):1005–1006Google Scholar
  3. 3.
    Graham MM, Norris CM, Galbraith PD et al (2006) Quality of life after coronary revascularization in the elderly. Eur Heart J 27(14):1690–1698PubMedCrossRefGoogle Scholar
  4. 4.
    Graham MM, Ghali WA, Faris PD et al (2002) Survival after coronary revascularization in the elderly. Circulation 105(20):2378–2384PubMedCrossRefGoogle Scholar
  5. 5.
    Anonymous (2001) Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME). A randomised trial. Lancet 358(9286):951–957CrossRefGoogle Scholar
  6. 6.
    Di Chiara A, Chiarella F, Savonitto S et al (2003) Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ study. Eur Heart J 24(18):1616–1629PubMedCrossRefGoogle Scholar
  7. 7.
    Newman MF, Kirchner JL, Phillips-Bute B et al (2001) Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344(6):395–402PubMedCrossRefGoogle Scholar
  8. 8.
    Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113(14):1799–1806PubMedCrossRefGoogle Scholar
  9. 9.
    Shaw RE, Anderson HV, Brindis RG et al (2002) Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998–2000. J Am Coll Cardiol 39(7):1104–1112PubMedCrossRefGoogle Scholar
  10. 10.
    De Servi S, Cavallini C, Dellavalle A et al (2004) Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome. Am Heart J 147(5):830–836PubMedCrossRefGoogle Scholar
  11. 11.
    Bach RG, Cannon CP, Weintraub WS et al (2004) The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004 141(3):186–195Google Scholar
  12. 12.
    de Araujo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R (2005) TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 26(9):865–872PubMedCrossRefGoogle Scholar
  13. 13.
    Morrow DA, Antman EM, Charlesworth A et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102(17):2031–2037PubMedGoogle Scholar
  14. 14.
    Silber S, Albertsson P, Aviles FF et al (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26(8):804–847PubMedCrossRefGoogle Scholar
  15. 15.
    Van de Werf F, Ardissino D, Betriu A et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24(1):28–66PubMedCrossRefGoogle Scholar
  16. 16.
    Holmes DR Jr, White HD, Pieper KS et al (1999) Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol 33(2):412–419PubMedCrossRefGoogle Scholar
  17. 17.
    Thiemann DR, Coresh J, Schulman SP et al (2000) Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 101(19):2239–2246PubMedGoogle Scholar
  18. 18.
    Antoniucci D, Valenti R, Santoro GM et al (1999) Systematic primary angioplasty in octogenarian and older patients. Am Heart J 138(4 Pt 1):670–674PubMedCrossRefGoogle Scholar
  19. 19.
    Migliorini A, Moschi G, Valenti R et al (2006) Routine percutaneous coronary intervention in elderly patients with cardiogenic shock complicating acute myocardial infarction. Am Heart J 152(5):903–908PubMedCrossRefGoogle Scholar
  20. 20.
    Wang YC, Hwang JJ, Hung CS et al (2006) Outcome of primary percutaneous coronary intervention in octogenarians with acute myocardial infarction. J Formos Med Assoc 105(6):451–458PubMedCrossRefGoogle Scholar
  21. 21.
    Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomized trials of antiplatlet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308:81–106Google Scholar
  22. 22.
    Cannon CP, Turpie AG (2003) Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy. Circulation 107(21):2640–2645PubMedCrossRefGoogle Scholar
  23. 23.
    Iakovou I, Dangas G, Mehran R et al (2003) Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥ 75 years of age versus those < 75 years of age. Am J Cardiol 92(9):1083–1086PubMedCrossRefGoogle Scholar
  24. 24.
    Lincoff AM, Bittl JA, Harrington RA et al (2003) Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289(7):853–863PubMedCrossRefGoogle Scholar
  25. 25.
    Lincoff AM, Kleiman NS, Kereiakes DJ et al (2004) Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 292(6):696–703PubMedCrossRefGoogle Scholar
  26. 26.
    Urban P, Gershlick AH, Guagliumi G et al; e-Cypher Investigators (2006) Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 113:1434–1441PubMedCrossRefGoogle Scholar
  27. 27.
    Archbold RA, Robinson NM, Schilling RJ (2004) Radial artery access for coronary angiography and percutaneous coronary intervention. Brit Med J 329(7463):443–446PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Francesco Bovenzi
    • 1
  • Roberto Lorenzoni
    • 1
  • Mauro Lazzari
    • 1
  • Andrea Boni
    • 1
  • Cristina Gemignani
    • 1
  1. 1.Division of CardiologyCampo di Marte HospitalLuccaItaly

Personalised recommendations